. Group 1 showed statistically signi cant higher levels of AEAbs IgA than patients without microangiopathy -0,353 (0,173÷0,471) vs. 0,235 (0,098÷0,377) ( W = 3,36; p = 0.05) and healthy controls -0,353 (0,173÷0,471) vs. 0,006 (0,052÷0,068) ( W = 20,37; p < 0,0001) (0.37 ± 0,03 vs. 0
INTRODUCTION
Total cholesterol (TC)/high-density lipoprotein cholesterol (HDL) TC/HDL and low-density lipoprotein cholesterol (LDL) LDL/HDL ratios are used to predict ischaemic heart disease risk. The atherogenic index (AI) can be estimated as log TC/HDL [1] . Non-HDL cholesterol (total cholesterol_HDL) includes all known and potential atherogenic lipid particles that predict further cardiovascular disease [2] [3] [4] . Total cholesterol/HDL ratio has been reported to be associated with metabolic abnormalities predictive of cardiovascular risk and related to insulin resistance [5, 8] . Triglyceride/HDL ratio has been reported as a marker of insulin resistance and small LDL [9, 10] .
The extracellular matrix protein elastin is responsible for the major part of tissue elasticity and is an insoluble component of elastic bers in the skin, lung and arteries [11, 12] . The detection of circulating elastinderived peptides (EDP) in the serum of healthy subjects, shows that the elastin macromolecule is not fully degraded by elastases in vivo. These EDP may become a stimulus for immunocompetent cells and for the production of anti-elastin antibodies (AEAbs) [13, 14, 15, 16] . Alterations in elastin structure and function lead to some pathologies of the arteries and lung [17] . Several elastase-type proteases, which selectively hydrolyze elastin, are present in smooth muscle cells, platelets, endothelial cells and broblasts [18] . During pathological processes these enzymes can be released and the result is degradation of elastic tissue. The following ndings support the thesis that soluble EDP are released and they appear in the circulation [19] . These EDP are immunogenic and induce speci c antibody production [20, 21] . Therefore, in the present study we quantitavely studied basement membrane elastin in the sera of type 2 diabetic patients with AH. Patients were divided in two groups according to presence or absence of microangiopathy. We also tested the hypothesis that lipid indices might have an association with ECM (extracellular matrix) main protein elastin turnover and with the development of microvascular complications.
Patients with type 2 diabetes mellitus are at high risk for vascular disease. This risk is increased with existence of arterial hypertension. In diabetic patients morbidity and mortality are mainly related to the presence of late complications, namely macro-and microangiopathy.
To the best of our knowledge, a relationship between lipid indices and immunological aspects of elastin turnover in diabetics with arterial hypertension has not been reported yet. The aim of this study was to identify a possible association between lipid indices, AEAbs and development of microvascular complications in patients with type 2 diabetes mellitus and arterial hypertension. We present the results of the determination of anti-elastin antibodies of different immunoglobulin classes (IgG, IgM and IgA) and lipid indeces in subjects with type 2 diabetes mellitus and arterial hypertension.
MATERIAL AND METHODS

Subjects
The experimental group consisted of 93 patients (37 men, 56 women) with type 2 diabetes mellitus and arterial hypertension (mean age 61,4 ± 11,3 years, diabetes duration 9,88 ± 3,12 years; hypertension duration 9,28 ± 4,98). These values were compared to serum antibodies to elastin in 42 age and sex-matched controls with no family history of diabetes, atherosclerosis or emphysema. All patients signed an informed consent prior to the initiation of the study.
Diabetics were divided in two groups according to the presence -Group 1 (n = 67) or absence -Group 2 (n = 26) of microvascular complications (Table 1) . Group 1 consisted of 39% men and 61% women. Fifty-ve percent were smokers and 45% were nonsmokers. Group 2 consisted of 42% men and 58% women. Fifty-eight percent were smokers and 42% non-smokers. Controls consisted of 45% men and 55% women. Twenty-seven percent were smokers and 73% non-smokers (Table 2 ). Microalbuminuria was de ned as a persistent urinary albumin excretion rate (AER) in the range of 20 to 200 g/min in sterile urine. None of the patients had a diagnosis of renal disease unrelated to diabetes during the followup period.
Procedures
I. ELISA
Anti-elastin antibodies (IgG, IgM and IgA) were measured by an enzyme-linked immunosorbent assay (ELISA). ELISA included the following steps:
Coating of polystyrene plates with human aortic -elastin, prepared as described by Baydanoff et al. [3] , (1 g of elastin in 100 l of 0.05 M carbonate buffer, pH 9.6).
Blocking of the remaining "active" centres of the polystyrene wells by polystyrene plate incubation for 24 h with 1% solution of bovine serum albumin (BSA) (SIGMA, USA) in phosphate buffered saline (PBS), pH 7.4, containing 0.05% Tween 20.
Incubation with test human sera diluted 1:10 with PBS for 1 h at 37°C.
Incubation with immunoconjugates (anti-human immunoglobulin peroxidase conjugates (SIGMA, USA) to heavy chain of IgG, IgM and IgA) for 1 h at 37°C. All immunoconjugates were diluted 1:10,000 with PBS containing 1% BSA and 0.05% Tween 20.
Incubation with substrate solution (o-phenylenediamine, 4 mg/ml in 10 ml 0.05 M citrate buffer, pH 5.0 + 0.01% H 2 O 2 for 1 h at room temperature in a dark chamber).
The reaction was stopped by adding of 4M sulfuric acid to each polystyrene well. All the extinction values were read at 492 nm using a Microelisa Reader 210 (OrganonTeknika, Belgium).
The following controls of the reaction were used: 1) Substrate control. The elastin-coated wells were incubated directly with substrate solution; 2) Immunoconjugate control. The speci city of each immunoconjugate was tested once against polystyrene elastin-coated wells (without human samples) and then against wells coated with immunoglobulins of the remaining two classes, e.g. the immunoconjugate against IgG was tested against human IgM and IgA. All the samples were tested in triplicate and peripheral wells were not used to avoid so called "bordering" effect. Intra-assay variation was less than 6% and inter-assay variation was less than 10%.
II. Other tests performed
1. Ophthalmoscopy through dilated pupils was carried out in all diabetic patients by the same ophthalmologist.
2. Glycated haemoglobin was measured using highpressure liquid chromatography (normal range of HbA1c -4-6%).
3. Serum total cholesterol and triglyceride concentrations were measured by enzyme assay (Boehringer Mannheim, Mannheim, Germany).
4. Arterial blood pressure was measured using a standard mercury sphygmomanometer, to the nearest 2 mm Hg, in the dominant arm after at least 10 min rest in the supine position.
5. AER was determined by nephelometry using a commercial kit containing speci c antibody (Behringwerke AG, Marburg, Germany). 
Statistical analyses
All data are presented as mean ± SD. Statistical analyses were done using the computer programs EXCEL and STATGRAPHICS plus for WINDOWS. The Student t-test and ANOVA were used to assess differences between the groups. The correlation and regression analyses were used. The level of signicance was determined as p < 0.05.
RESULTS
Patients with T2DM and AH showed signi cantly higher levels of serum AEAbs IgA than healthy con- Male patients with T2DM and AH showed statistically signi cant higher ratio of TC/HDL than female patients 7,2 (5,3÷9,0) vs. 5,2 (3,9÷6,2) (KW = 8,07; P = 0.004).
Male patients with T2DM and AH showed statistically signi cant higher ratio of LDL/HDL than female patients 4,1 (3,1÷5,8) vs. 2,9 (2,0÷4,5) (KW = 5,85; P = 0.01).
Log TG/HDL values in men were higher than these in women but this differences are not statistically signicant (Table 4) (Fig. 2) .
DISCUSSION
The atherogenic index of plasma (AIP) (log TG/HDL) is calculated in an attempt to predict cardiovascular risk. In the scope of AIP, triglycerides and HDL refer to the relationship of atherogenic lipids to protective lipids. The AIP has been related to cardiovascular risk in clinical trials. Values less than 0.11 are classi ed as low cardiovascular risk, between 0.11 to The total cholesterol TC/HDL ratio is more indicative of cardiovascular disease than TC (total cholesterol), if HDL and LDL in the blood are added together. For men an acceptable ratio of TC/HDL is 4.5 or below, and for women is 4.0 or below. HDL levels have an inverse relationship with coronary heart disease. The ability of HDL to predict the development of coronary atherosclerosis has been estimated to be four times higher than LDL and eight times -than TC.
For men an acceptable ratio of LDL/HDL is 3.6 or below, and for women -3.2 or below. In adults, the triglyceride TG/HDL-"good" cholesterol ratio should be below 2. More precisely, the triglyceride/HDL ratio of 2 or less is considered ideal, 4 -high, and 6 -extremely high. People with the highest ratio of triglycerides to HDL had 16 times the risk of heart attack as those with the lowest ratio of triglycerides to HDL in the study of 340 heart attack patients and 340 of their healthy, same age counterparts. The ratio of triglycerides to HDL was the strongest predictor of a heart attack, even more accurate than the LDL/HDL ratio [22] .
Epidemiological studies have shown a strong relationship between diabetes mellitus, arterial hypertension and cardiovascular disease. In diabetic patients morbidity and mortality are mainly related to the presence of late complications, namely macro-and microangiopathy. Diabetes mellitus (both type 1 and type 2) is a major risk factor for cardiovascular disease [23] . In the Framingham Study, the risk of cardiovascular disease was doubled by the presence of diabetes [24] .
Arterial hypertension and diabetic vascular complications are connected with an elevated degradation of elastic tissue. As a result soluble EDP are released in the circulated blood, which are a pathological stimulus for an increased production of AEAbs. Because it is very important to nd characteristics of pathological activation of elastin turnover, we studied diabetic patients with arterial hypertension. Our data suggest an association between the activity of elastin turnover (especially increased serum levels of IgA AEAbs) and vascular complications. In a recent investigation, patients with microvascular complications showed statistically signi cant higher levels of AEAbs IgA than patients without micrangiopathy and healthy controls. AEAbs IgA showed correlation with systolic blood pressure, too. Serum levels of AEAb IgG and IgM in patients with T2DM and AH were lower than in controls, but these differences are not statistically signi cant.
The rst immunoglobulin synthesised during the early phase of a pathologically activated immune response is IgM. The immune system then switches to production of IgG. The elevation of AEAbs of the IgM and IgG types is, therefore, the rst indicator of the pathological turnover of elastin and the development of vascular complications in diabetic patients. That is a possible explanation of our results. The later rise in the level of IgA AEAbs and its association with diabetic microvascular complications may be explained as follows: IgA AEAb may be "spared" by the phagocytes, which mainly possess receptors for the Fcfragments of IgG and IgM. Thus, the elimination of IgG bound to a speci c antigen will be greater than that of IgA [25] during the later stages of the development of vascular complications.
Our data suggest an association between the activity of elastin turnover, high lipid indices and vascular complications. We found that the values of AEAbs IgA in patients with vascular complications are signi cantly higher than in patients without vascular damages and healthy controls. This means that the diabetics from Group 1 show pathologically high immune response to elastin. Although the data from Group 2 reveals levels of IgA AEAbs higher than those of the controls, these levels still remain lower than the measured in patients with vascular complications from Group 1. It is extremely important to monitor if the group of patients with high levels of IgA AEAbs will develop vascular lesions before the patients without such elevated levels of IgA AEAbs. We suppose that the high lipid indices indicate a higher probability of the development of vascular changes in these patients, particularly in those from group 1. According to our results, determination of serum AEAbs IgA seem to be a useful method for identifying a high atherosclerotic risk in diabetic patients with hypertension.
Extracellular matrix proteins -collagen type IV (CIV) and elastin -are uniquely present in basement membranes and represent their predominant structural element. Metabolic alteration of elastin occurs mainly in the microvascular basement membrane of diabetic patients. Arterial hypertension and diabetes mellitus are connected with an elevated degradation of elastic tissue, loss of elasticity, increasing rigidity of arterial wall, and abnormal increase in the collagen/elastin ratio. As a result soluble elastin (EDP) derived peptides are released in the circulated blood, which are a pathological stimulus for an increased production of anti-elastin (AEAbs) antibodies.
There Interestingly, AEAbs IgA did not show correlation with the serum total cholesterol and triglyceride levels but correlated with high lipid indices. That is why we suppose that lipid indices are more strongly associated with development of ECM dysfunction (because of correlation with elastin antibodies) and development of vascular lesions than widespread use of routine lipid markers. Probably lipid ratios and especially TC/ HDL and TG/HDL ratio are more useful for identi cation of subjects who are more susceptible to microvascular complications than isolated determination of these variables. It is known that the elevated levels of serum triglycerides which contain multiple types of potential atherogenic lipoproteins enrich the picture of diabetic dyslipidemia. It is the most common deviation in poorly controlled diabetes. In patients with microvascular complications the attachment of triglycerides to the arterial wall can lead to the conversion of elastin into an immunogenic form [31, 32] . In the present study, the triglycerides were elevated over the normal range in patients with vascular complications which supports the idea about this feature.
Identi cation of biological markers would allow more aggressiveness in the achievement of tight glycaemic control and a better search for initial lesions in those patients who are predisposed to complications than in those who are not. The understanding of the relation between high lipid indices, the altered pattern of expression of various antibodies and the dysregulated vascular remodeling at the level of the target tissue would allow design of therapeutic approach targeted to the individual tissue and to the relevant biochemical, functional and structural alterations. Our study shows, that determination of biological markers of ECM turnover and lipid indices can be useful in monitoring vascular injury.
In conclusion, our results suggest an association between the level of anti-elastin IgA antibodies, high lipid indices and the development of vascular wall lesions in patients with diabetes mellitus type two. Elevation of AEAbs IgA may indicate increased elastin degradation and development of microvascular complications. However, a larger study is necessary for clari cation of these possibilities.
